FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028390790> ?p ?o ?g. }

• W2028390790 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CABackground: Protein lysine methyltransferases (PKMTs) are a class of histone modifiers that have recently been reported to be mutated, amplified and overexpressed in a variety of cancers and are emerging as attractive targets for drug development. Squamous cell carcinoma of the head and neck (SCCHN) is a common malignancy with a poor prognosis. Recently, we found that WHSC1, a protein methyltransferase of the NSD family of PKMTs (NSD1, WHSC1/NSD2, WHSC1L1/NSD3), is overexpressed in 75% of SCCHN patients. In addition, the TCGA project recently reported that the NSD-family of PKMTs is altered in 26% of SCCHN patients in a mutually exclusive pattern. Given the above and the fact that an upcoming WHSC1-inhibitor is under development, we decided to further investigate the role of WHSC1 as a mediator of oncogenesis and thus as a potential novel therapeutic target for SCCHN.Methods: Cytotoxicity assays (MTTs) were performed in one HPV-positive and 3 HPV-negative SCCHN cell lines using WHSC1-specific siRNAs. Annexin V assays were performed to evaluate whether cell death was mediated through apoptosis. Cell cycle analysis by flow cytometry was also performed. Immunohistochemistry for WHSC1 and H3K36me2 was conducted in a cohort of 123 patients with SCCHN. To identify downstream targets of WHSC1, cDNA microarrays were conducted in a loss-of-function SCCHN cell line. ChIP assays were performed to assess transcriptional downstream targets directly regulated by WHSC1. Immunoprecipitation assays and mass spectrometry analysis were conducted and candidate substrates were further characterized by in vitro methyltransferase assay.Results: Knockdown of WHSC1 with WHSC1-specific siRNAs caused significant growth suppression in 4 SCCHN cell lines. Cell death was mediated partially through induction of apoptosis, as evidence by an increase of sub-G1 and annexin V-positive cells. Cell cycle analysis also revealed a significant decrease in the S-phase cells. Survival correlations of WHSC1 in a cohort of 123 SCCHN patients is currently underway. cDNA microarray analysis revealed that knockdown of WHSC1 in a SCCHN cell line was associated with downregulation of genes involved in cellular differentiation, apoptosis and mitosis, including NEK7, MAPK8 and HIPK3, which were validated with qPCR. NEK7 was further validated to be downregulated at the protein level after WHSC1 knockdown. ChIP assay for NEK7 revealed that WHSC1 directly binds to four different gene body regions of NEK7.Conclusions: Based on these data, it is possible that WHSC1 may function as a driver of oncogenesis in SCCHN, and could thus serve as a novel therapeutic target for this disease. With a WHSC1-inhibitor already under development, advancing our knowledge of the function of WHSC1 and the other NSD-PKMTs in SCCHN and other cancer types with NSD-aberrancies could accelerate the introduction of relevant inhibitors in clinical trials.Citation Format: Vassiliki Saloura, Makoto Nakakido, Houda Alachkar, Tanguy Seiwert, Mark Lingen, Ezra Cohen, Yusuke Nakamura, Ryuji Hamamoto. Wolf-Hirschhorn syndrome candidate 1 as a potential novel therapeutic target for head and neck cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5153. doi:10.1158/1538-7445.AM2014-5153" @default.
• W2028390790 created "2016-06-24" @default.
• W2028390790 creator A5003617778 @default.
• W2028390790 creator A5008467612 @default.
• W2028390790 creator A5008513060 @default.
• W2028390790 creator A5011852177 @default.
• W2028390790 creator A5013717696 @default.
• W2028390790 creator A5058226349 @default.
• W2028390790 creator A5067324005 @default.
• W2028390790 creator A5079171795 @default.
• W2028390790 date "2014-09-30" @default.
• W2028390790 modified "2023-09-25" @default.
• W2028390790 title "Abstract 5153: Wolf-Hirschhorn syndrome candidate 1 as a potential novel therapeutic target for head and neck cancer" @default.
• W2028390790 doi "https://doi.org/10.1158/1538-7445.am2014-5153" @default.
• W2028390790 hasPublicationYear "2014" @default.
• W2028390790 type Work @default.
• W2028390790 sameAs 2028390790 @default.
• W2028390790 citedByCount "0" @default.
• W2028390790 crossrefType "proceedings-article" @default.
• W2028390790 hasAuthorship W2028390790A5003617778 @default.
• W2028390790 hasAuthorship W2028390790A5008467612 @default.
• W2028390790 hasAuthorship W2028390790A5008513060 @default.
• W2028390790 hasAuthorship W2028390790A5011852177 @default.
• W2028390790 hasAuthorship W2028390790A5013717696 @default.
• W2028390790 hasAuthorship W2028390790A5058226349 @default.
• W2028390790 hasAuthorship W2028390790A5067324005 @default.
• W2028390790 hasAuthorship W2028390790A5079171795 @default.
• W2028390790 hasConcept C104317684 @default.
• W2028390790 hasConcept C121608353 @default.
• W2028390790 hasConcept C153911025 @default.
• W2028390790 hasConcept C173396325 @default.
• W2028390790 hasConcept C29537977 @default.
• W2028390790 hasConcept C33288867 @default.
• W2028390790 hasConcept C502942594 @default.
• W2028390790 hasConcept C54355233 @default.
• W2028390790 hasConcept C555283112 @default.
• W2028390790 hasConcept C81885089 @default.
• W2028390790 hasConcept C86803240 @default.
• W2028390790 hasConcept C91965660 @default.
• W2028390790 hasConceptScore W2028390790C104317684 @default.
• W2028390790 hasConceptScore W2028390790C121608353 @default.
• W2028390790 hasConceptScore W2028390790C153911025 @default.
• W2028390790 hasConceptScore W2028390790C173396325 @default.
• W2028390790 hasConceptScore W2028390790C29537977 @default.
• W2028390790 hasConceptScore W2028390790C33288867 @default.
• W2028390790 hasConceptScore W2028390790C502942594 @default.
• W2028390790 hasConceptScore W2028390790C54355233 @default.
• W2028390790 hasConceptScore W2028390790C555283112 @default.
• W2028390790 hasConceptScore W2028390790C81885089 @default.
• W2028390790 hasConceptScore W2028390790C86803240 @default.
• W2028390790 hasConceptScore W2028390790C91965660 @default.
• W2028390790 hasLocation W20283907901 @default.
• W2028390790 hasOpenAccess W2028390790 @default.
• W2028390790 hasPrimaryLocation W20283907901 @default.
• W2028390790 hasRelatedWork W1564090234 @default.
• W2028390790 hasRelatedWork W1625422028 @default.
• W2028390790 hasRelatedWork W2010352507 @default.
• W2028390790 hasRelatedWork W2016302087 @default.
• W2028390790 hasRelatedWork W2021546830 @default.
• W2028390790 hasRelatedWork W2031470200 @default.
• W2028390790 hasRelatedWork W2039733767 @default.
• W2028390790 hasRelatedWork W2062689591 @default.
• W2028390790 hasRelatedWork W2066014398 @default.
• W2028390790 hasRelatedWork W2072138655 @default.
• W2028390790 hasRelatedWork W2072622278 @default.
• W2028390790 hasRelatedWork W2321021639 @default.
• W2028390790 hasRelatedWork W2331081899 @default.
• W2028390790 hasRelatedWork W2331885308 @default.
• W2028390790 hasRelatedWork W2334770952 @default.
• W2028390790 hasRelatedWork W2485444233 @default.
• W2028390790 hasRelatedWork W2741612900 @default.
• W2028390790 hasRelatedWork W3083374382 @default.
• W2028390790 hasRelatedWork W3132016047 @default.
• W2028390790 hasRelatedWork W3190647696 @default.
• W2028390790 isParatext "false" @default.
• W2028390790 isRetracted "false" @default.
• W2028390790 magId "2028390790" @default.
• W2028390790 workType "article" @default.